FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
Top NewsMost Read Highlighted
Get AlertsSRPT Hot Sheet
BUY ( Up)
Trading fraudsters are at it again Wednesday.
Shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) fell out of bed mid-day after a Twitter account posing to be influential short selling firm Citron Research made a negative mention of the stock. The stock fell as much as 10 percent before recovering. Shares last traded up 3.5% to $28.13.
@citreonresearc
“$SRPT FDA steps in as its 48 weeks results on Eteplirsen results are tainted and have been doctored they believeTrial papers seized by FDA.”
Twitter has since suspended this account.
A similar occurrence happened Tuesday when a Twitter account posing as Muddy Waters Research issued a tweet about Audience (NASDAQ: ADNC). The real Muddy Waters called it a “hoax.” Shares of Audience plunged 24% intra-day before recovering and closing up 4.5%.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW